This study is aimed to characterize Russian population of Retinitis Pigmentosa
Age range
6 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes in visual acuity
Timeframe: Up to 4 weeks
Changes in structures of fundus of the eye-1
Timeframe: Up to 4 weeks
Changes in structures of fundus of the eye-2
Timeframe: Up to 4 weeks
Changes in visual field
Timeframe: Up to 4 weeks
Changes in brain visual cortex neural pathways
Timeframe: Up to 4 weeks
Changes in electroretinogram
Timeframe: Up to 4 weeks
Changes in optical refraction
Timeframe: Up to 4 weeks
Changes in intraocular pressure
Timeframe: Up to 4 weeks
Changes in the lens, cornea, anterior segment of the eye
Timeframe: Up to 4 weeks
Changes in central retinal profile
Timeframe: Up to 4 weeks